Search News Archives
Social Media
Will BRIC be the Savior for the Life Sciences and Medical Devices Sector? Seal of Approval for Pepceuticals ZEISS Lightsheet Z.1 awarded with Best New Life Science Product of 2012 IDT and SGI-DNA Broaden Their Collaboration to Provide Synthetic DNA Products up to 2 Mbp Watson-Marlow OEM pumps help push the boundaries of automated cell culture Breakthrough in non-invasive gut health testing New Portable SPECTROSCOUT XRF Analyzer - the Lab that Goes Anywhere ZEISS SIGMA used to analyze Russian meteorite that fell in Chelyabinsk region
Waters Updates Alliance HPLC Designs Without Impacting Established Validated Methods Porvair Sciences Expands Product Range for Epigenetics Thermo Fisher Scientific Introduces Gas Chromatography Headspace Autosampler for Organic Volatiles New Amicon® Pro Purification System for Protein Purification from Merck Millipore Wyatt Calypso Succeeds in ABRF-MIRG Study Revolutionize your pipetting with the new Biohit Picus electronic pipette Easy, Reliable Weighing in Regulated Areas Phenom proX all-in-one desktop SEM Flash of inspiration in the shaft tunnel - IKA launches the new video for UTTD control The only Chromatography Autosampler you will ever need! JG Finneran Associates introduces the 96-Well Multi-Tier Microtiter Plate System (Patented) IC for the people – Metrohm celebrates 25 years of ion chromatography
For further information or to sign up to receive any of our E-Newsletters click here Reading and Imaging are Combined in BioTek's Revolutionary, New Cytation™3 ZEISS SIGMA used to analyze Russian meteorite that fell in Chelyabinsk region New SPOT Insight™ Gigabit Camera Brings Microscopy Presentations to Life ZEISS Lightsheet Z.1 awarded with Best New Life Science Product of 2012 Malvern’s Dr E Neil Lewis takes his place among chemical imaging pioneers Waters Biopharmaceutical, Bioanalysis and Screening Solutions Now Shipping with UNIFI 1.6 New Software for Research & Scientific Thermal Imagers Thermo Fisher Scientific Introduces Data System to Unite Chromatography and Mass Spectrometry Molecular Devices Introduces SoftMax Pro 6 GxP Microplate Data Acquisition and Analysis Software Short Guide to 3D Cell Culture New EFS Handbook Published by Lee Products The Perfect Ultrafiltration Device for Your Specific Need Electron Magnetic Resonance shrinks to fit the undergraduate curriculum Biotage Releases New Catalog and Technical Guide for Sample Preparation and Evaporation New Waters Quality Parts, Chromatography Columns and Supplies Catalog
|
PRECOS Secures Multi Year Global Service Agreement with Leading Pharmaceutical Company
publication date: Nov 26, 2010
|
author/source: The Scott Partnership
PRECOS was launched as a spin-off from the University of Nottingham, UK in August 2010. The master services agreement is a consolidation of the working relationship between the two companies, which was first established with the University of Nottingham over five years ago. The newly formed company combines the innovation of one of the Country's leading universities with the scientific background and expertise of multi-disciplinary scientists. This places it in an optimal position to deliver specialist services, backed by significant industry expertise and cutting-edge technology, to help both pharmaceutical and biotechnology companies develop new anti-cancer drugs. PRECOS offers patient-relevant models which closely reflect the patient situation for each aspect of cancer progression encompassing pre-cancerous lesions, primary tumours and metastasis. Chief Scientific Officer of PRECOS, Professor Sue Watson, comments: "This global contract further strengthens the long term relationship between PRECOS and Janssen and consolidates PRECOS' evolution from a primarily academic background into an ambitious commercial entity, offering significant scientific expertise and delivering highly specialist services in the development of new anti-cancer drugs." Dr. Martin Page, Vice President, Head of Global Oncology Research, Janssen Research & Development, a division of Janssen Pharmaceutica N.V. comments: "Our agreement with PRECOS is a natural extension of our long-standing relationship with the University of Nottingham; we look forward to continuing to build on our past successes." For further information please visit www.precos.co.uk |
|
Preclinical Oncology Services Limited (PRECOS), a leading pre-clinical research and development service provider with a specific focus on oncology, has signed a significant service agreement with a leading global pharmaceutical company Janssen Pharmaceutica N.V. (Janssen). The global contract will see PRECOS provide clinical tumour material, tumour model development, target validation and drug efficacy work to support Janssen's oncology drug discovery, development and biomarker programmes.